Suppr超能文献

成人肝移植术后晚期停用泼尼松可降低糖尿病、高血压和高胆固醇血症的发生率,且不会导致移植物丢失。

Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss.

作者信息

Stegall M D, Everson G T, Schroter G, Karrer F, Bilir B, Sternberg T, Shrestha R, Wachs M, Kam I

机构信息

Department of Surgery, The University of Colorado School of Medicine, Denver 80262, USA.

出版信息

Hepatology. 1997 Jan;25(1):173-7. doi: 10.1002/hep.510250132.

Abstract

We prospectively withdrew prednisone in 28 adult patients who had stable graft function more than 2 years after orthotopic liver transplantation (OLTx) and had been on 5 mg/d prednisone for at least 6 months. Prednisone was decreased from 5 mg/d to 2.5 mg/d for 1 month then stopped completely. Cyclosporine monotherapy was maintained at a level of approximately 200 ng/mL (TDX). Nineteen patients had prednisone withdrawn without complications. Four (14.2%) had modest elevations in liver function tests (two biopsy proven mild rejections and two were not biopsied). These four were treated with methylprednisolone boluses and then withdrawal of steroids again. Prednisone was restarted in five patients because of generalized fatigue and body aches (n = 4) and colitis (n = 1). Steroids later were successfully withdrawn in two of these patients. After prednisone withdrawal, three of five insulin-dependent diabetic patients were able to discontinue insulin therapy and their glycosylated hemoglobin levels improved. Four of fourteen hypertensive patients were able to discontinue antihypertensive medicines. Mean serum cholesterol decreased from 222.6 +/- 43.3 to 188.3 +/- 33.3 mg/dL (P < .001). The number of patients with serum cholesterol levels > 220 mg/dL decreased from 13 to 4. A control group of 24 patients maintained on 5 mg/d prednisone at least 2 years after liver transplantation also was studied. In this group during the study period, no diabetic became normoglycemic, no patient decreased their antihypertensive medicine, and the mean serum cholesterol levels did not change significantly. We conclude that prednisone withdrawal using cyclosporine monotherapy late after liver transplantation does not lead to graft loss and decreases the prevalence of diabetes, hypertension, and hypercholesterolemia. Symptoms occurring during withdrawal may be minimized by earlier or slower tapering.

摘要

我们前瞻性地对28例原位肝移植(OLTx)术后2年以上移植肝功能稳定且服用5mg/d泼尼松至少6个月的成年患者停用泼尼松。泼尼松从5mg/d减至2.5mg/d,持续1个月,然后完全停药。环孢素单药治疗维持在约200ng/mL(TDX)的水平。19例患者停用泼尼松无并发症。4例(14.2%)肝功能检查有轻度升高(2例经活检证实为轻度排斥反应,2例未行活检)。这4例患者接受甲泼尼龙冲击治疗,然后再次停用类固醇。5例患者因全身乏力和身体疼痛(4例)以及结肠炎(1例)重新开始使用泼尼松。其中2例患者后来成功停用类固醇。停用泼尼松后,5例胰岛素依赖型糖尿病患者中有3例能够停用胰岛素治疗,糖化血红蛋白水平改善。14例高血压患者中有4例能够停用降压药。血清总胆固醇均值从222.6±43.3降至188.3±33.3mg/dL(P<0.001)。血清胆固醇水平>220mg/dL的患者人数从13例降至4例。还研究了一个对照组,24例肝移植术后至少2年维持服用5mg/d泼尼松的患者。在该组研究期间,没有糖尿病患者血糖恢复正常,没有患者减少降压药用量,血清总胆固醇均值也没有明显变化。我们得出结论,肝移植后期使用环孢素单药治疗停用泼尼松不会导致移植物丢失,并可降低糖尿病、高血压和高胆固醇血症的患病率。停药期间出现的症状可通过更早或更缓慢地减量来尽量减少。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验